Core Conclusion We maintain an Overweight view on Almarai. The potential for a SAR 0.5 price increase in its core Saudi fresh dairy segment (23% of sales), not embedded in consensus, presents a clear near-term earnings catalyst. Factoring in probable market share attrition, this could add 5-10% to annual EPS. Combined with a high-single-digit EPS CAGR from a resilient business and a valuation at a ~35% discount to its historical average, the risk-reward is compelling.
What the Market is Mispricing The market appears to be assigning a low probability to a meaningful price increase in Saudi fresh dairy, likely due to concerns over consumer sensitivity and competitive dynamics. However, history shows such increases are implemented to recoup rising structural costs, not merely commodity inflation. With EBIT margins 335 bps below 2019 levels due to elevated diesel, labor, and lower subsidies, the fundamental cost justification for pricing action is stronger than perceived.
Evidence Chain Conclusion: A SAR 0.5 price hike is the historical norm and offers substantial earnings leverage. Historical precedent over 15 years shows all fresh dairy price increases were in SAR 0.5 increments, typically during periods of cost pressure. A SAR 0.5 increase on 1-liter milk implies an 8% price rise. Evidence: Modeling indicates a SAR 0.5 increase, assuming 80% portfolio coverage, would add ~SAR 350mn to net profit before elasticity, driving ~15% annual EPS accretion and lifting EBIT margins by ~130 bps into the mid-point of management's 14-16% target range. Investment Implication: This represents a direct, high-margin earnings uplift not reflected in current forecasts, where our base case already embeds 30 bps of EBIT margin expansion for 2026 from cost efficiencies alone.
Conclusion: Competitive response, not consumer demand, is the primary determinant of post-increase market share. The earnings benefit will be moderated by volume elasticity, which is largely a function of whether competitors follow. Evidence: In 2018, when peers held prices, Almarai lost ~3 ppts of value share immediately but saw a partial recovery. In 2020-22, when the industry raised prices in unison to offset costs, Almarai's share remained stable. Investment Implication: The net EPS benefit is therefore a function of competitive dynamics. Sensitivity analysis shows that with a 1-2% value share loss—a plausible outcome—the annual EPS upside moderates to a still-material 5-10% range.
Conclusion: A margin-recovery narrative supports valuation re-rating beyond a one-time pricing event. Almarai's current valuation discount reflects margin compression and high capex. Successful pricing action would signal a turning point in profitability. Evidence: At ~15.5x NTM P/E, the stock trades at a ~35% discount to its 10-year average and only a 5% premium to the Saudi Consumer sector, versus a historical 20% premium. EBIT margins (13.9% in 2025) remain well below the 17.2% achieved in 2019. Investment Implication: A demonstrated ability to recover margins through pricing in its largest segment could catalyze a valuation re-rating towards historical levels, providing a second leg of upside alongside earnings growth.
Key Divergences & Risks The primary debate centers on the timing and competitive reaction to any price move. Weak consumer sentiment and geopolitical uncertainty may delay action or prompt a more phased, smaller increase. A scenario where competitors refrain from following (as in 2018) could lead to greater-than-modeled share loss (~3 ppts), potentially neutralizing the EPS benefit. Regulatory scrutiny is an ever-present risk in the staple dairy category, though a cost-recovery rationale has historically been accepted. Finally, a prolonged downturn in the poultry segment remains a headwind to overall group margins.
Valuation & Trading Implications At SAR 41.02, trading at 15.4x 2026e P/E, the valuation offers an attractive entry point for a market leader with a defensible growth profile. The investment case does not rely on a price increase, being underpinned by a high-single-digit EPS CAGR. However, the potential for a 5-10% EPS uplift from pricing provides a near-term optionality not priced in. A successful execution could drive shares toward a ~20x P/E multiple, closer to historical norms, implying meaningful re-rating potential. The key monitorable is management commentary on cost pressure and pricing philosophy.
Appendix: Data Summary
| Scenario (1L Milk Price) | EPS Accretion (Pre-Elasticity) | Net Profit Impact (SAR mn) |
|---|---|---|
| +SAR 0.50 (to SAR 6.50) | c. +14% | c. +350 |
| With 1% Value Share Loss | c. +6% to +10% | c. +150 to +250 |
| With 2% Value Share Loss | c. +1% to +6% | c. -25 to +150 |
Key Forecasts (MSe): 2026-28e Revenue CAGR: +6.9%; EPS CAGR: +9.4%; 2026e EBIT Margin: 14.2% (+30 bps y/y).